Article
06 May 2026
Peptides At The Crossroads: FDA Tightens The Line As Category 2 Pushes Toward Category 1
CONTRIBUTING SINCE MARCH 2011
Buchanan Ingersoll & Rooney PC
With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
POPULAR TOPICS
Food, Drugs, Healthcare, Life Sciences
Cannabis & Hemp
International Law
Employment and HR
Energy and Natural Resources
DETAILS
United States
+1 412 562 8800
Union Trust Building
501 Grant Street
Suite 200
Pittsburgh
United States
Contact Firm
COMPANY CONTENT
Article
06 May 2026
What FDA’s Latest Peptide Action Really Means For Compounding Pharmacies
Article
06 May 2026
The Illusion Of PBM Transparency: What Plan Sponsors Must Learn From The OPM OIG Audit Of CVS Caremark
Article
05 May 2026
Shaking Up The Workplace: USDOL's Proposed Joint Employment Rule And Its Impact On Employers
Article
30 Apr 2026
House Plaintiffs Move To Exempt Multimedia Rights NIL Deals From Clearinghouse Review
Article
29 Apr 2026
Navigating The Strait Of Hormuz: U.S. Sanctions And Global Oil Markets
Article
28 Apr 2026
The Critical First 30 Days: A Defense Perspective On Managing Traumatic Accident Claims
Article
28 Apr 2026
Cosmetics Industry Update: What’s New With MoCRA?
Article
10 Apr 2026
Ohio Legislatures Sign PBM Reform Into Law
Article
08 Apr 2026
That Free Trial Might Cost You: "Automatic Renewal" Litigation On The Rise In CA
Article
06 Apr 2026
NIL Reform Efforts Gain Momentum: University Proposals And Federal Attention Signal Potential Structural Change
Article
06 Apr 2026
SEC Clarifies The Application Of The Securities Laws To Crypto Assets
Article
31 Mar 2026
CVS Caremark Settles FTC Insulin Pricing Lawsuit: Key Developments And Industry Impact
Article
30 Mar 2026
One Strike And You’re Out: Strikethrough Pricing And Perpetual Promotion Claims Surge
Article
27 Mar 2026
Antiboycott Compliance: Department Of The Treasury Publishes List Of Countries Requiring Cooperation With An International Boycott
Article
27 Mar 2026
Board Of Pharmacy Enforcement Is Accelerating: What Pharmacies And Industry Stakeholders Need To Do Now
Article
24 Mar 2026
Breaking Barriers: Mastering FDA Regulations, National Security, And Tariffs To Expand Your MedTech Company To The U.S.
Article
24 Mar 2026
Is The IRS Holding Your Money? How The Kwong Ruling Impacts Pandemic-Era Tax Refunds For Individuals, Companies, And Non-Profit Organizations
Article
23 Mar 2026
New Draft Guidance From FDA On Flavored Vape Products
Article
23 Mar 2026
The Consolidated Appropriations Act Of 2026: What Plan Sponsors And Pharmacies Need To Know And How To Use It
AWARDS
